Have a project
in mind?
Every project begins with one conversation. No commitment. No sales pitch. Just an honest discussion about where you are, what you need, and whether KOM is the right partner to help you get there.
Every project begins with one conversation. No commitment. No sales pitch. Just an honest discussion about where you are, what you need, and whether KOM is the right partner to help you get there.
Creating a deeptech or biotech company is not a linear process. It requires legal precision, financial engineering, scientific credibility, and communication coherence. KOM coordinates all of it, with the right specialists at every stage.
Most communication agencies stop at the pitch deck. Most law firms stop at the articles of association. Most accountants stop at the financial model. Most incubators stop at the end of the programme. KOM does not stop.
The Strategy Division was built on a single observation: researcher-entrepreneurs in deeptech and biotech need a coordinator who understands both the scientific environment they are coming from and the investment ecosystem they are entering — and who can bring the right specialist into the room at the right moment, without the founder having to find them alone. That coordinator is KOM. And the specialists — a corporate lawyer for the legal structure and the shareholders' agreement, a biotech-specialist chartered accountant for the financial architecture, patent attorneys for IP strategy — are part of the KOM partner network, engaged on every dossier where their expertise is required.
IP legal audit, risk mapping, dependency analysis, choice of legal structure — SAS, SA, or Ltd. MRSEI application support for projects with a European dimension.
Articles of association, shareholders' agreement, founder capitalisation table, equity instruments (BSA AIR, BSPCE) and IP partner observer seat on the board.
Bpifrance Competition, French Tech Emergence Grant, France 2030, TRL maturation funds.
Seed structuring €500k–€1M, health business angels and regional funds, Series A preparation €3–€5M (M15–M18), introductions to VCs.
TRL mapping and investor data room, R&D partnership contracts SAS↔LabCom, CIFRE PhDs and know-how transfer, exclusive sub-licence negotiation.
Biotech-specialist chartered accountant, corporate and IP deeptech lawyer, patent attorneys for IP strategy and negotiations, VC and industry introductions in the health sector.
The KOM partner network is not a directory of contacts passed to the client on request. It is a structured set of specialist relationships — each partner engaged on specific dossiers, coordinated by KOM, and held to the same standard of precision and scientific literacy that KOM brings to every mandate.
Specialist in deeptech and biotech company law — articles of association, shareholders' agreements, BSPCE and BSA AIR equity instruments, co-ownership and sub-licence negotiations, tripartite agreements between founders, research institutions, and tech transfer offices. Your legal structure is not a template. It is the governance architecture of a company that will be scrutinised by investors at every round.
Financial architecture designed for the specific constraints of a life sciences spin-off — founder capitalisation table, non-dilutive funding eligibility (CIR, i-Lab, France 2030), seed and Series A financial modelling, investor data room, and ongoing financial oversight through the fundraising cycle. Present from the first free strategic meeting and engaged throughout the company lifecycle.
IP audit before incorporation, patent portfolio assessment, sub-licence structuring, freedom-to-operate analysis, and ongoing IP strategy as the technology advances along the TRL scale. An asset without a clear IP narrative is systematically undervalued at licence-out and at every subsequent fundraising round.
Selective activation of phases based on immediate priorities — legal structure only, or non-dilutive funding support only, or data room preparation for a specific round. 50/50 payment structure (upfront / on delivery). No bundled discount. Maximum flexibility. Best for: Pre-seed startups · Researchers at the pre-creation stage
All three divisions integrated — Communication, Horizon Europe where relevant, and Strategy — with a consistent national and European narrative from day one. 15% partner discount. Free initial strategic meeting with chartered accountant and corporate lawyer included. Best for: Founders ready to incorporate · Researchers with an active EU project
Equity and deferred payment model reducing upfront cash requirements. Remaining value is performance-linked via BSA AIR or deferred to EU funding close or fundraising round. KOM is aligned with your project's success, not just its deliverables. Best for: Early-stage deeptech · EIC Pathfinder / Accelerator candidates
Adding {{itemName}} to cart
Added {{itemName}} to cart